Fox 5 San Diego1mon
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit
So what: If you purchased Pacira securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Fox 5 San Diego1mon
Shareholders that lost money on Pacira BioSciences, Inc. (PCRX) should contact Levi & Korsinsky about pending Class Action - PCRX
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit.
Business Insider29d
PCRX Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Pacira BioSciences, Inc.
SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira ...
Nature4mon
Pacira BioSciences: Pioneers in the commitment to nonopioid pain management
Pacira BioSciences, Inc., is a global leader in the nonopioid pain management and regenerative medicine spaces, with a commitment to helping advance and improve the patient journey along the ...